Our Pipeline and Products

Menarini is investing in advanced science and technology to develop a pipeline of new products that make a difference to the lives of patients affected by serious conditions.

MENARINI is a fully integrated privately owned pharma company with a long and successful heritage in strategic partnering across the globe. We have a profound know-how stemming from our strong R&D capabilities in key therapeutic areas, coupled with our excellence in commercial execution and our powerful direct presence on a global basis.

Share your partnering idea

Our dedicated Corporate Business Development team is committed to assess and explore innovative new opportunities.

 

Donations of backpacks and cases for school, distribution of meals and medicines, promotion of sport, support for pregnant women and much more: being responsible for Menarini means transforming good intentions into concrete efforts. By helping others, we want to contribute to improve the world around us, starting with us.

Our Values

Everyday we put our values into action. 4 values, which have given life to Menarini and shaped its history.

 

What does it really make Menarini unique? The diversity and authenticity of our key resource - the People.
Our cultural diversity helps us to drive innovation, adapt to business changes, face challenges, inspire ideas and develop our growth.

Available positions on Linkedin

Menarini employees make all the difference, every day.

 

News

14th International Congress on Autoimmunity

2024/05/17-2024/05/20

Ljubljana (Slovenia)

The International Congress on Autoimmunity is the largest multidisciplinary congress that covers all aspects of related diseases, offering lectures and courses by some of the world’s most renowned experts. This year it will be held in Ljubljana which is a beautiful city with a rich history and cultural heritage. This stunning location will provide the perfect backdrop for discussions on all aspects of autoimmunity diagnostics. We are pleased to participate in this congress and to have the opportunity to present our renewed solutions designed to improve lab productivity and to support clinical decisions.

14th International Congress on Autoimmunity 0